General Biochemistry Panel
- UID
- IMP/IVD/2020/001079_e380508fbb6dd138f873211142ec7ff2_30927eadf7a93d7b4ad95a306cf90c49
- Device class
- Class B
- Brand name
- Skyla
- License holder
- Kin Diagnostics
- Approving authority
- CDSCO
- Product information
- The skyla General Biochemistry Panel used with skyla Clinical Chemistry Analyzer, is intended to be used for the quantitative determination of Albumin (Skyla), Alkaline Phosphatase (Skyla), Alanine Aminotransferase (Skyla), Aspartate Aminotransferase (Skyla), Blood Urea Nitrogen (Skyla), Creatinine (Skyla), Gamma-Glutamyl Transpeptidace (Skyla), Blood Glucose (Skyla), Total Bilirubin (Skyla), Total Cholesterol (Skyla), Total Protein (Skyla), Uric Acid (Skyla) in human whole blood, plasma, or serum. The calculated values of Albumin/Globulin Ratio (Skyla), Estimated Glomerular Filtration Rate (Skyla) , and Globulin (Skyla) can then be obtained
General Biochemistry Panel is a medical device registered with India's Central Drugs Standard Control Organization (CDSCO) under UID IMP/IVD/2020/001079_e380508fbb6dd138f873211142ec7ff2_30927eadf7a93d7b4ad95a306cf90c49. This device is marketed under the brand name Skyla. The license holder is Kin Diagnostics, and it is classified as Device Class Class B. The approving authority is CDSCO.
This page provides comprehensive regulatory information including complete registration details, license holder information, device classification, and related products. Pure Global AI offers free access to 71,807+ India medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.